Navigation Links
WaveSense Reduces Diabetes Testing Cost by 50%
Date:6/4/2009

SALEM, N.H., June 4 /PRNewswire/ -- The makers of the WaveSense(TM) line of blood glucose monitoring products (AgaMatrix, Inc.) announced today their continued commitment to providing low cost, high accuracy, and high quality blood glucose monitoring (BGM) products for people with diabetes. The WaveSense Presto(TM) BGM can be found at leading retailers nationwide, including Wal-Mart(R) and Kroger(R). Presto test strips (50 ct) are often as low as $22.88, less than half the typical price of strips from major brands.

The high cost of testing supplies can cause financial hardship for people with diabetes who do not have complete health insurance coverage or who do not have insurance. Often times products that sell at lower prices are not high accuracy or high quality, do not have a proven track record of meter and strip placement in the market, and are not readily available to consumers. WaveSense products feature a new technology that makes testing accurate and affordable and they are used by hundreds of thousands of patients worldwide.

"WaveSense provides the LSU Health Care Services Division outpatient pharmacies the means to provide a high quality, affordable blood glucose monitoring system to our patient population," said Danny Jackson, System Director of Pharmacy for the LSU Health Care Services Division. "The no coding feature and the benefits of WaveSense accuracy deliver a premium, easy-to-use system to the market at a price point that makes testing possible for those patients with limited or no health insurance."

Affordable BGM testing has become increasingly important given today's economic environment. Furthermore, the number of people with diabetes is growing each year, causing both public and private health insurance to spend even more money treating the disease. Marian Batts-Turner, a leading certified diabetes educator (CDE) and member of the American Association of Diabetes Educators (AADE) Board of Directors said, "There is indisputable evidence that better glycemic control decreases the risk of complications in people with diabetes, such as cardiovascular disease and kidney failure. WaveSense technology uniquely enables affordable systems for patients to monitor their blood sugar accurately and reliably."

For more information on WaveSense products, go to: http://www.wavesense.info.

About WaveSense:

WaveSense(TM) is a line of blood glucose meters and strips designed to improve the quality of diabetes care by using a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. Current products include the WaveSense KeyNote(TM), WaveSense KeyNote Pro(TM), WaveSense Presto(TM), WaveSense Jazz(TM), and Zero-Click(TM), a diabetes data management system designed to simplify data download.

(C) 2002-2009 AgaMatrix, Inc. WaveSense; Presto; Pro; KeyNote; WaveSense Jazz; and Zero-Click are trademarks of AgaMatrix, Inc. Wal-Mart and Kroger are registered trademarks of their respective owners.


'/>"/>
SOURCE AgaMatrix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New WaveSense Presto(TM) and Pro(TM) Glucose Meters to Simplify Testing
2. Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
3. Text Messaging Medication Reminders Significantly Reduces Organ Rejection in Pediatric Liver Transplant Recipients
4. Intervention reduces delinquent teenage pregancy rates
5. New blood test greatly reduces false-positives in prostate cancer screening
6. Mayo study finds that team preop briefing improves communication, reduces errors
7. Mayo Study Finds That Team Preop Briefing Improves Communication, Reduces Errors
8. BioRays CytoFlora Reduces Digestive and Behavioral Issues in Autistic Children
9. Folic Acid Reduces Infant Heart Defects
10. 3-Drug Combo Reduces Nausea After Chemo
11. Dr. Elliot Jacobs' New 'Hypo Lipo' Procedure Permanently Reduces Hyperhidrosis and Body Odor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... Centennial, CO (PRWEB) , ... August 20, 2017 , ... ... in the same household? If so, you may be interested in participating in ... The purpose of this research is to understand more about the relational aspects of ...
(Date:8/19/2017)... York, New York (PRWEB) , ... August 19, ... ... Street Health has announced that it is the first organization with pending recognition ... CDC’s National Diabetes Prevention Program (“DPP”) via group telehealth classes and live video ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners ... Orlando location as an interventional pain management physician. He brings a wealth of ... of migraine headaches, and significant experience in spinal cord stimulation for chronic pain. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... ... The Dawn Johnson Insurance Group, a Missouri-based insurance and financial planning firm ... for efforts to educate the local population on cancer realities while attracting donations to ... , Each day in America, roughly 4,600 new cases of cancer are diagnosed and ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
Breaking Medicine Technology: